Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors

被引：80

作者：

Chen, Jianyong

Bai, Longchuan

Bernard, Denzil

Nikolovska-Coleska, Zaneta

Gomez, Cindy

Zhang, Jian

Yi, Han

Wang, Shaomeng ^{[1
]}

机构：

[1] Univ Michigan, Ctr Comprehens Canc, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2010年 / 1卷 / 02期

关键词：

STAT3; inhibitor; SH2; domain; apoptosis; SOLID-PHASE SYNTHESIS; SIGNAL TRANSDUCER; SMALL-MOLECULE; PEPTIDOMIMETIC INHIBITORS; SH2; DOMAIN; DIMERIZATION; ACTIVATOR; TARGETS; BINDING; PHOSPHOPEPTIDES;

D O I：

10.1021/ml100010j

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We report herein the structure-based design of a class of conformationally constrained, potent, cell-permeable small-molecule inhibitors to target the SH2 domain in STAT3. Compound 11 (CJ-1383) binds to STAT3 with a K-i value of 0.95 mu M, dose-dependently inhibits cellular STAT3 signaling and cancer cell growth, and induces apoptosis in the MDA-MB-468 cancer cell line with constitutively activated STAT3.

引用

收藏

页码：85 / 89

页数：5

相关论文

共 26 条

[1] Three-dimensional structure of the Stat3β homodimer bound to DNA [J].

Becker, S ;

Groner, B ;

Müller, CW .

NATURE, 1998, 394 (6689) :145-151

[2] The role of STATs in transcriptional control and their impact on cellular function [J].

Bromberg, J ;

Darnell, JE .

ONCOGENE, 2000, 19 (21) :2468-2473

[3] Stat3 as an oncogene [J].

Bromberg, JF ;

Wrzeszczynska, MH ;

Devgan, G ;

Zhao, YX ;

Pestell, RG ;

Albanese, C ;

Darnell, JE .

CELL, 1999, 98 (03) :295-303

[4]

Buettner R, 2002, CLIN CANCER RES, V8, P945

[5] Design and synthesis of a new, conformationally constrained, macrocyclic small-molecule inhibitor of STAT3 via 'click chemistry' [J].

Chen, Jianyong ;

Nikolovska-Coleska, Zaneta ;

Yang, Chao-Yie ;

Gomez, Cindy ;

Gao, Wei ;

Krajewski, Krzysztof ;

Jiang, Sheng ;

Roller, Peter ;

Wang, Shaomeng .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) :3939-3942

[6] Solid phase synthesis of phosphopeptides incorporating 2,2-dimethyloxazolidine pseudoproline analogs:: Evidence for trans leu-pro peptide bonds in Stat3 inhibitors [J].

Coleman, David R. ;

Kaluarachchi, Kumaralal ;

Ren, Zhiyong ;

Chen, Xiaomin ;

McMurray, John S. .

INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2008, 14 (01) :1-9

[7] Investigation of the binding determinants of phosphopeptides targeted to the Src homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor [J].

Coleman, DR ;

Ren, ZY ;

Mandal, PK ;

Cameron, AG ;

Dyer, GA ;

Muranjan, S ;

Campbell, M ;

Chen, XM ;

McMurray, JS .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) :6661-6670

[8] Transcription factors as targets for cancer therapy [J].

Darnell, JE .

NATURE REVIEWS CANCER, 2002, 2 (10) :740-749

[9] Small molecule inhibitors of Stat3 signaling pathway [J].

Deng, Jinxia ;

Grande, Fedora ;

Neamati, Nouri .

CURRENT CANCER DRUG TARGETS, 2007, 7 (01) :91-107

[10] New syntheses of tetrazolylmethylphenylaianine and O-malonyltyrosine as pTyr mimetics for the design of STAT3 dimerization inhibitors [J].

Dourlat, Jennifer ;

Valentin, Bruno ;

Liu, Wang-Qing ;

Garbay, Christiane .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) :3943-3946